PROCTER & GAMBLE HEALTH | ALEMBIC | PROCTER & GAMBLE HEALTH/ ALEMBIC |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.7 | 31.9 | 108.9% | View Chart |
P/BV | x | 10.6 | 1.2 | 904.9% | View Chart |
Dividend Yield | % | 2.0 | 2.3 | 86.3% |
PROCTER & GAMBLE HEALTH ALEMBIC |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
ALEMBIC Mar-23 |
PROCTER & GAMBLE HEALTH/ ALEMBIC |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 87 | 6,167.4% | |
Low | Rs | 3,883 | 56 | 6,993.9% | |
Sales per share (Unadj.) | Rs | 740.7 | 5.0 | 14,948.4% | |
Earnings per share (Unadj.) | Rs | 138.2 | 3.1 | 4,402.9% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 3.4 | 4,561.7% | |
Dividends per share (Unadj.) | Rs | 95.00 | 2.20 | 4,318.2% | |
Avg Dividend yield | % | 2.1 | 3.1 | 66.5% | |
Book value per share (Unadj.) | Rs | 447.6 | 80.9 | 553.1% | |
Shares outstanding (eoy) | m | 16.60 | 256.78 | 6.5% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 14.4 | 43.4% | |
Avg P/E ratio | x | 33.5 | 22.7 | 147.4% | |
P/CF ratio (eoy) | x | 29.8 | 21.0 | 142.3% | |
Price / Book Value ratio | x | 10.3 | 0.9 | 1,173.2% | |
Dividend payout | % | 68.7 | 70.1 | 98.1% | |
Avg Mkt Cap | Rs m | 76,761 | 18,298 | 419.5% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 240 | 857.5% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 1,272 | 966.4% | |
Other income | Rs m | 184 | 643 | 28.6% | |
Total revenues | Rs m | 12,480 | 1,915 | 651.7% | |
Gross profit | Rs m | 3,247 | 297 | 1,092.3% | |
Depreciation | Rs m | 281 | 67 | 418.0% | |
Interest | Rs m | 8 | 5 | 165.6% | |
Profit before tax | Rs m | 3,142 | 868 | 362.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 62 | 1,371.3% | |
Profit after tax | Rs m | 2,295 | 806 | 284.6% | |
Gross profit margin | % | 26.4 | 23.4 | 113.0% | |
Effective tax rate | % | 27.0 | 7.1 | 378.8% | |
Net profit margin | % | 18.7 | 63.4 | 29.5% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 1,721 | 680.4% | |
Current liabilities | Rs m | 6,791 | 838 | 810.3% | |
Net working cap to sales | % | 40.0 | 69.4 | 57.7% | |
Current ratio | x | 1.7 | 2.1 | 84.0% | |
Inventory Days | Days | 263 | 5,038 | 5.2% | |
Debtors Days | Days | 343 | 673 | 51.1% | |
Net fixed assets | Rs m | 10,617 | 20,324 | 52.2% | |
Share capital | Rs m | 166 | 514 | 32.3% | |
"Free" reserves | Rs m | 7,265 | 20,267 | 35.8% | |
Net worth | Rs m | 7,431 | 20,780 | 35.8% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 22,330 | 22,046 | 101.3% | |
Interest coverage | x | 409.1 | 187.7 | 218.0% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.6 | 0.1 | 954.1% | |
Return on assets | % | 10.3 | 3.7 | 280.3% | |
Return on equity | % | 30.9 | 3.9 | 796.0% | |
Return on capital | % | 42.4 | 4.2 | 1,009.4% | |
Exports to sales | % | 0 | 1.2 | 0.0% | |
Imports to sales | % | 13.1 | 2.4 | 555.6% | |
Exports (fob) | Rs m | NA | 16 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 30 | 5,369.2% | |
Fx inflow | Rs m | 1,465 | 16 | 9,344.4% | |
Fx outflow | Rs m | 1,605 | 30 | 5,369.2% | |
Net fx | Rs m | -140 | -14 | 985.9% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 389 | 607.4% | |
From Investments | Rs m | -215 | 73 | -294.7% | |
From Financial Activity | Rs m | -985 | -464 | 212.3% | |
Net Cashflow | Rs m | 1,160 | -2 | -48,345.8% |
Indian Promoters | % | 0.0 | 70.9 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 1.1 | 1,799.1% | |
FIIs | % | 6.2 | 1.1 | 583.2% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 29.1 | 165.5% | |
Shareholders | 56,778 | 99,130 | 57.3% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA ZYDUS LIFESCIENCES DR. REDDYS LAB
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | ALEMBIC | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.13% | -0.16% | 0.53% |
1-Month | -0.85% | 17.22% | 2.63% |
1-Year | 1.04% | 53.73% | 56.27% |
3-Year CAGR | -8.66% | -5.53% | 15.25% |
5-Year CAGR | 5.03% | 17.34% | 19.65% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the ALEMBIC share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of ALEMBIC the stake stands at 70.9%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of ALEMBIC.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
ALEMBIC paid Rs 2.2, and its dividend payout ratio stood at 70.1%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of ALEMBIC.
For a sector overview, read our pharmaceuticals sector report.
Asian shares rose cautiously on Friday as markets sobered up to the idea that U.S. rate cuts were most likely some time away.